The Anti-Science Streak in Federal Marijuana Policy - Conor Friedersdorf - National - The AtlanticQuicklink submitted by Mari Eliza Permalink
|The classification of cannabis as a schedule one narcotic is among the least defensible aspects of prohibition. Dr. Jody Corey-Bloom, director of the Multiple Sclerosis Center at UC San Diego, recently helped run a study that provided multiple sclerosis patients with either a marijuana joint or a placebo that looked, smelled, and tasted like marijuana. After smoking whichever substance they were given, patients were tested to see if it reduced their muscle spasticity -- an affliction, common to MS patients, that causes painful, uncontrollable spasms of the extremities. Spasticity was unaffected among the placebo patients but dropped 30 percent on average among the patients given real marijuana. The side effects? 'Smoking caused fatigue and dizziness in some users,' says Reuters, 'and slowed down people's mental skills soon after they used marijuana.'|
The time limit for entering new comments on this Quicklink has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.